Reviewed by Michael Gill, B. Sc.
23 Diabetic Kidney Disease Clinical Trials Near Me
Top Hospitals for Diabetic Kidney Disease Clinical Trials
Image of Mayo Clinic in Rochester in Minnesota.
Mayo Clinic in Rochester
Rochester
3Active Trials
3All Time Trials for Diabetic Kidney Disease
2018First Diabetic Kidney Disease Trial
Image of Research by Design, LLC in Illinois.
Research by Design, LLC
Chicago
2Active Trials
5All Time Trials for Diabetic Kidney Disease
2017First Diabetic Kidney Disease Trial
Top Cities for Diabetic Kidney Disease Clinical Trials
Image of San Antonio in Texas.
San Antonio
7Active Trials
Clinical Advancement Center, PLLCTop Active Site
Image of Boston in Massachusetts.
Boston
5Active Trials
Brigham and Women's HospitalTop Active Site
Top Treatments for Diabetic Kidney Disease Clinical Trials
Treatment Name
Active Diabetic Kidney Disease Clinical Trials
All Time Trials for Diabetic Kidney Disease
First Recorded Diabetic Kidney Disease Trial
INV 202 10 mg
1
1
2022
canagliflozin
1
1
2022
Glucagon-like peptide-1 receptor agonist (GLP-1 RA)
1
1
2022
Montelukast
1
1
2022
Individualized basic need navigation and lifestyle coaching
1
1
2022
Recently Completed Studies with FDA Approved Treatments for Diabetic Kidney Disease
Treatment
Year
Sponsor
CSL346
2020
CSL Behring

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 7th, 2021

Last Reviewed: November 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Frazier R, Mehta R, Cai X, Lee J, Napoli S, Craven T, Tuazon J, Safdi A, Scialla J, Susztak K, Isakova T. Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes. Kidney Int Rep. 2018 Sep 18;4(1):94-102. doi: 10.1016/j.ekir.2018.09.006. eCollection 2019 Jan. https://pubmed.ncbi.nlm.nih.gov/305961722 Leehey DJ, Carlson K, Reda DJ, Craig I, Clise C, Conner TA, Agarwal R, Kaufman JS, Anderson RJ, Lammie D, Huminik J, Polzin L, McBurney C, Huang GD, Emanuele NV. Pentoxifylline in diabetic kidney disease (VA PTXRx): protocol for a pragmatic randomised controlled trial. BMJ Open. 2021 Aug 16;11(8):e053019. doi: 10.1136/bmjopen-2021-053019. https://pubmed.ncbi.nlm.nih.gov/344004613 Davis TM, Ting R, Best JD, Donoghoe MW, Drury PL, Sullivan DR, Jenkins AJ, O'Connell RL, Whiting MJ, Glasziou PP, Simes RJ, Kesäniemi YA, Gebski VJ, Scott RS, Keech AC; Fenofibrate Intervention and Event Lowering in Diabetes Study investigators. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia. 2011 Feb;54(2):280-90. doi: 10.1007/s00125-010-1951-1. Epub 2010 Nov 4. https://pubmed.ncbi.nlm.nih.gov/21052978